The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksERGO.L Regulatory News (ERGO)

  • There is currently no data for ERGO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

3 Oct 2023 15:02

RNS Number : 5657O
Ergomed plc
03 October 2023
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BN7ZCY67

Issuer Name

ERGOMED PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Morgan Stanley

City of registered office (if applicable)

 

Country of registered office (if applicable)

US

Name

City of registered office

Country of registered office

Morgan Stanley

Wilmington, Delaware

USA

4. Details of the shareholder

Name

City of registered office

Country of registered office

Morgan Stanley & Co. International plc

London

UNITED KINGDOM

5. Date on which the threshold was crossed or reached

29-Sep-2023

6. Date on which Issuer notified

03-Oct-2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

5.134230

0.000000

5.134230

2615511

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BN7ZCY67

2615511

5.134230

Sub Total 8.A

2615511

5.134230%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Morgan Stanley (Chain 1)

Morgan Stanley (Chain 1)

Morgan Stanley International Holdings Inc.

Morgan Stanley (Chain 1)

Morgan Stanley International Limited

Morgan Stanley (Chain 1)

Morgan Stanley Investments (UK)

Morgan Stanley (Chain 1)

Morgan Stanley & Co. International plc

5.134230

5.134230%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

03-Oct-2023

13. Place Of Completion

Glasgow

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFSAFDDEDSEIS
Date   Source Headline
2nd Jun 20234:48 pmRNSTR1 Notification
26th May 20238:38 amRNSNotice of AGM and Annual Report
19th Apr 20237:00 amRNSDirector's Dealing
17th Apr 20237:00 amRNSHolding(s) in Company
13th Apr 20233:27 pmRNSHoldings in Company
3rd Apr 20239:51 amRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
30th Mar 20233:37 pmRNSHolding(s) in Company
21st Mar 20237:00 amRNSErgomed Preliminary Results 2022
17th Mar 202311:39 amRNSHoldings in Company
1st Mar 20237:07 amRNSTotal Voting Rights
16th Feb 20231:44 pmRNSHolding(s) in Company
14th Feb 20237:01 amRNSNotice of Preliminary Results
1st Feb 20237:00 amRNSTotal Voting Rights
25th Jan 20237:00 amRNSJonathan Curtain appointed CFO
25th Jan 20237:00 amRNSErgomed 2022 Trading Update
20th Jan 20235:23 pmRNSHolding(s) in Company
20th Jan 20239:38 amRNSHolding(s) in Company
3rd Jan 20237:00 amRNSTotal Voting Rights and Block Listing Return
5th Dec 20227:00 amRNSDirector Dealings
2nd Dec 20227:00 amRNSJohn Dawson appointed Senior Independent Director
1st Dec 20227:00 amRNSTotal Voting Rights
22nd Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
21st Nov 202210:46 amEQSErgomed (ERGO): Two key management changes
17th Nov 20227:00 amRNSErgomed Strengthens Executive Management Team
16th Nov 20227:00 amRNSExercise of Share Options and Total Voting Rights
1st Nov 20224:16 pmRNSExercise of Share Options and Total Voting Rights
1st Nov 20227:00 amRNSTotal Voting Rights
20th Oct 20222:09 pmRNSHolding(s) in Company
14th Oct 20224:09 pmRNSHolding(s) in Company
13th Oct 20227:00 amRNSHolding(s) in Company
4th Oct 202212:52 pmEQSErgomed (ERGO): Poised for a strong FY22
3rd Oct 20227:00 amRNSTotal Voting Rights
27th Sep 20227:00 amRNSErgomed Interim results 2022
2nd Sep 20227:00 amRNSHolding(s) in Company
1st Sep 20227:00 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSErgomed Notice of Results
19th Aug 20222:49 pmRNSHolding(s) in Company
1st Aug 20228:10 amEQSErgomed (ERGO): Sustained growth momentum in H122
1st Aug 20227:00 amRNSDirector Dealing
1st Aug 20227:00 amRNSTotal Voting Rights
26th Jul 20227:00 amRNSErgomed H1 2022 Trading Update
1st Jul 20227:00 amRNSTotal Voting Rights and Block Listing Return
10th Jun 202211:21 amRNSResults of 2022 Annual General Meeting
10th Jun 20227:00 amRNSErgomed Annual General Meeting Statement
10th Jun 20227:00 amRNSAnne Whitaker appointed to the Board as NED
1st Jun 20227:00 amRNSErgomed plc Total Voting Rights
13th May 20227:00 amRNSErgomed Notice of AGM and Annual Report
3rd May 20228:49 amRNSErgomed plc Total Voting Rights
28th Apr 20227:01 amEQSErgomed (ERGO): Healthy fundamentals for 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.